Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104193792B reveals a one-step microwave-assisted conversion of chenodeoxycholic acid. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity ursodeoxycholic acid.
Patent CN105461662A details a cost-effective synthesis for anti-HIV drug intermediates using L-phenylalanine, offering supply chain stability and high purity for pharmaceutical manufacturing.
Patent CN105218502B details asymmetric synthesis of chiral chromans using squaric acid catalysts. Offers high purity and scalable routes for pharmaceutical intermediate manufacturing.
Novel method for (7S)-5-azaspiro[2.4]heptane-7-ylcarbamate tert-butyl ester. High optical purity, scalable process, cost-effective supply chain solutions for global pharma.
Novel Fe-catalyzed asymmetric synthesis of Bakuchiol. High yield, scalable process. Reliable supplier for pharmaceutical intermediates. Cost-effective manufacturing solution.
Patent CN101781197B reveals a high-yield route for chiral binaphthyl dicarboxylic acid. Achieve >99% optical purity without chromatography for cost-effective supply.
Patent CN115466288B reveals a room-temperature method for chiral diphosphine selenium ligands, offering high yield and simplified supply chains for asymmetric catalysis manufacturing.
Novel CDOP-based synthesis route offers cost-effective chiral ligands. Enhances supply chain stability and reduces manufacturing complexity for asymmetric synthesis applications.
Novel lacosamide synthesis avoiding toxic reagents. High yield, scalable process for reliable API intermediate supply chain partners.
Patent CN101472877A details a scalable route for chiral amino alcohols. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel acid-catalyzed benzylation and chiral addition route for high-purity benzoxazinone intermediates, offering scalable manufacturing and reduced heavy metal waste.
Novel iron-catalyzed route for (S)-flurbiprofen ensures high optical purity and scalable manufacturing for global pharmaceutical supply chains reducing costs significantly.
Novel carbapenem derivatives with extended half-life and broad-spectrum activity. Optimized synthesis routes for cost-effective pharmaceutical intermediate manufacturing.
Patent CN1743308A details an enzymatic asymmetric synthesis route for veterinary antibiotics, eliminating resolution waste and improving chiral purity.
Patent CN1743308A reveals an enzymatic asymmetric synthesis route for thiamphenicol and florfenicol intermediates, offering significant cost reduction and supply chain reliability for veterinary pharmaceutical manufacturing.
Novel sulfonylation route for Dapoxetine Hydrochloride ensures high optical purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN111606868B discloses a high-yield synthesis for bidentate oxazoline ligands. Discover cost-effective manufacturing and supply chain advantages for chiral intermediates.
Patent CN105418502B details a novel rare earth catalyzed route for high-purity Paroxetine intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel Lewis acid catalysis enables high-purity ornidazole enantiomers with simplified workflow and substantial supply chain cost advantages for global buyers.
Patent CN118598836A reveals a novel asymmetric synthesis route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.